Literature DB >> 14018556

Clinical studies with vincristine.

P P CARBONE, V BONO, E FREI, C O BRINDLEY.   

Abstract

Entities:  

Keywords:  ALKALOIDS; ANTINEOPLASTIC AGENTS

Mesh：

Substances：

Year:  1963        PMID： 14018556

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  Microtubule-disrupting chemotherapeutics result in enhanced proteasome-mediated degradation and disappearance of tubulin in neural cells.

Authors:  Lyn M Huff; Dan L Sackett; Marianne S Poruchynsky; Tito Fojo
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

2.  The effects of colcemid on hematopoiesis in the mouse.

Authors:  P A Bunn; S E Shackney; S S Ford
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

Review 3.  [Chemotherapy-induced peripheral neuropathy and neuropathic pain].

Authors:  U Schuler; S Heller
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

4.  Vincristine-induced neuropathy in rat: electrophysiological and histological study.

Authors:  Feras M H Ja'afer; Farqad B Hamdan; Faiq H Mohammed
Journal:  Exp Brain Res       Date:  2006-05-31       Impact factor: 1.972

5.  Vindesine. A clinical trial with special reference to neurological side effects.

Authors:  R Obrist; U Paravicini; D Hartmann; G A Nagel; J P Obrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Clinical trial of pyridoxine to reduce vincristine neurotoxicity.

Authors:  D V Jackson; E K Pope; R A McMahan; M R Cooper; J N Atkins; R D Callahan; E H Paschold; R A Grimm; J O Hopkins; H B Muss
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

7.  Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.

Authors:  F Cervantes; E Montserrat; C Rozman; C Diumenjo; E Feliu; A Grañena
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

8.  VINCRISTINE IN THE TREATMENT OF NEOPLASTIC DISEASE.

Authors:  D M WHITELAW; H S KIM
Journal:  Can Med Assoc J       Date:  1964-06-20       Impact factor: 8.262

Review 9.  Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions.

Authors:  James J Steinhardt; Ronald B Gartenhaus
Journal:  Clin Cancer Res       Date:  2012-06-27       Impact factor: 12.531

10.  Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 cases.

Authors:  P Fenaux; I Quiquandon; M T Caulier; M Simon; M P Walter; F Bauters
Journal:  Blut       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.